|
 |
 |
Genetic Transformation
M. Peng and P.J. Szaniszlo
|
Index:
(to jump to a listing, click on the desired name to the right) |
Materials
Protocol
Results
Tips |
|
Principle
and General Applications |
|
The ability to investigate the genetics of
fungi has been extended substantially by DNA-mediated transformation. Once a
transformation system is developed, it can play an important role in many fundamental
genetic analyses, such as those including gene replacement, gene disruption, and gene
cloning. Genetic transformation of Wangiella dermatitidis can be accomplished using
both electroporation and PEG-mediated methods.
Common strategies for selecting
transformants are based upon either prototrophic growth or drug/antibiotic resistance. In
our laboratory, two different plasmid vectors have been used for evaluating transformation
efficiencies. Plasmid, pAN7-1, contains the Escherichia coli hygromycin B
efficiencies. Plasmid, pAN7-1, contains the Escherichia coli hygromycin B (HmB)
phosphotransferase (hph) gene. Expression of the hph gene in the fungus confers resistance
to antibiotic HmB. Plasmid, pWU44, contains a URA5 gene from Podospora anserina.
The URA5 auxotroph of W. dermatitidis was transformed to protorophy with pWU44 by
complementation. These transformation methods are being used to investigate the molecular
genetics of W. dermatitidis. |
|
(Back to
the top) |
|
Materials |
|
Plasmids
pAN7-1 is common transformation vector for
filamentous fungi and contains the E. coli hph gene as a dorminant
selectable marker, under transcriptional control of the glyceraldehyde-3-phosphate
dehydrogenase (gpd) promoter and the tryptophan synthetase (trpC) terminator
signals from Aspergillus nidulans (Punt et al. 1987, Peng et al. 1992).pWU44 is
a Histoplasma capsulatum-E. coli telomeric shuttle vector and contains the
Podospora anserina URA5 gene as a selectable marker (Woods and Goldman 1993).
Strains
Strain8656 (ATCC 34100; Roberts and Szaniszlo
1978), wild type. Strain Mc3W-14, a cdc mutant strain with defects also in melanin
and uracil biosynthesis (cdc2, mel3-3, ura5-2; Cooper and Szaniszlo
1993; Cooper, Schafer and Szaniszlo, unpublished data).
Enzymes
Zymolyase-20T (ICN Immunobiologicals, Lisle,
IL). Spheroplasting Enzyme MIXX (BIO 101, La Jolla, CA).
Antibiotics
Hygromycin B (SIGMA, St. Louis, MO)
Media
MCD: This complete medium is prepared first
by adding the following components to 800 ml of distilled water: 30% (w/v) NaNo3,
10 ml; 20% (w/v) K2HPO4, 5 ml; 20% (w/v) MgSO4·7H20,
5 ml; 10% (w/v) KCl, 5 ml; dextrose, 30 g and adjusting to pH 6.5. Then, 1.0 g Bacto-yeast
extract (Difco, Detroit, MI) and 1 ml of a freshly-prepared FeSO4·7H20
(10mg·ml-1) are added and the volume adjusted to one liter by water.CDN:
This minimal medium is prepared as MCD medium, except the yeast extract is replaced by 3
mg thiamine and 5.3g NH5Cl for one liter of medium.
SOS: 2% (w/v) Bacto-tryptone (Difco), 0.5% (w/v) Bacto-yeast extract, 10mM NaCl, 2.5 mM
KCl, and 1 M sorbitol.
Buffers and Others
Buffer A: 0.5 M MgSO4 7H20
in 0.1 M Tris, final pH 7.2
Buffer B: 0.5 M CaCl2 in 0.1 M Tris, final pH 7.2.
Polyethylene glycol (PEG) solution: 25% (w/v) PEG-8000 in Buffer B.
Top agar: 1% molton Bacto-agar in Buffer B and held in 50 C
Sorbitol (ultra pure, transformation grade, BIO 101).
SCEM solution (BIO 101).
CaST solution (BIO 101).
10x SSPE solution: 1.8 M NaCl, 0.1 M Na5PO4, 10 mM EDTA, pH 7.7.
TAE buffer: 45 mM Tris acetate, 1mM EDTA, pH 8.0.
Carrier DNA (salmon sperm DNA) 10 mg·ml-1
Primer-A-Gene-Kit (Promaga, Madison, WI).
Nytran membrane (Schleicher and Schuell, Keene, NH).
Gene Pulse Apparatus (Bio-Rad Laboratories, Richmond, CA).
Gene Pulse Cuvette (0.2 cm electrode gap, Bio-Rad).
|
|
(Back to
the top) |
|
Protocol |
|
Spheroplasting
- Strains, 8656 and Mc3W-14, are grown for spheroplasting by inoculating yeast cells from
a single colony from a maintenance culturing plate of MCD agar [MCD with 15 g Bacto agar
(Difco) per liter] into 100 ml MCD and incubating with shaking at 25°C to an optimum cell
density of 2 X 106·ml-1 (O.D. = 0.3). Culture is for about 3-4
days.
- When sufficient cell mass is evident, spin to pellet cells in a 50 ml conical tube, 500
x g for 5 min, and discard supernatant
- Resuspend in 40 ml sterile H20, spin to pellet cells, 500 x g for 5 min.
- Gently resuspend cells in 40 ml Buffer A or 1 M sorbitol solution, spin 500 x g for 5
min, and discard supernatant.
- Resuspend cells in 10 ml Buffer A and add ß-mercaptoethanol to a final concentration of
100 mM. Incubate cells for 30 min at 37°C with shaking (150 rpm) and then add 50 µl
Spheroplasting Enzyme MIXX (10 mg·ml-1), and incubate for 1 hr at 30ºC. Check
spheroplasting by phase-contrast microscopy until 90-95% spheroplasting is reached.
- Spin to pellet spheroplasts, 500 x g for 5 min and wash with 40 ml Buffer B or 1M
sorbitol solution by centrifugation (500 x g for 5 min). Gently resuspend spheroplasts in
2 ml Buffer B or CaST solution and adjust to 2 X 108 cells·ml-1
final concentration of spheroplasts with the same solution. The spheroplasts are now ready
for transformation.
Transformation
Plasmid pAN7-1 has been used to transform
strain 8656 and plasmid pWU44 has been used to transform strain Mc3W-14, respectively
Electroporation
Electroporation experiments are conducted
with Buffer B-suspended spheroplasts in 0.2 cm electrode cap cuvettes at an electrical
condition of 2.6 KV·cm-1 field strength, 200 ohms resistance, and 25 µF
capacitance, corresponding to a time range of 5-10 msec, using a Gene Pulse Apparatus
(Bio-Rad). Mix 5-10 µg of plasmid DNA with 400 µl of spheroplast suspension and keep on
ice. Following delivery of the electrical pulse, add the suspension to 0.5 ml Buffer B,
Keep on ice for 10 min and gently shake the "clump" of spheroplasts to disperse
into small pieces.
PEG-mediated transformation
In a 6 ml Falcon round bottom tube (Becton
Dickinson Labware, Lincoln Park, NJ), add 1 µg of carrier DNA, 5-10 µg of plasmid DNA,
and 200 µl of spheroplast suspension. Gently swirl to mix. Incubate at room temperature
for 20 min. Then, add 1 ml PEG solution and swirl to mix. Incubate at room temperature for
10 min. Spin, 500 x g for 5 min, discard supernatant, and resuspend in 2000 µl of 1 M
sorbitol solution.
Spheroplast regeneration and transformant
selection
a. After transformation, mix 200 µl of
transformed spheroplast suspension with 200 µl of SOS medium and incubate at 30ºC for 40
min.
b. Mix the incubated spheroplast suspension with
5-7 ml of pre-warmed (50ºC) top agar and plate onto MCD agar containing 50-100 µg
HmB·ml-1 for selection of HmB resistant colonies transformed with pAN7-1 and
CND agar for selection of prototrophs transformed with pWU44 by complementation.
DNA Isolation and Southern analysis
Putative transformant DNA is prepared as
described in Ausubel et al. (1989). Digest DNA with restriction enzymes, such as EcoRI and
PstI, according to the suppliers instructions (Promaga) and electrophorese in an
0.9% agarose using a TAE buffer. Transfer this DNA to be analysed by Southern (1975)
hybridization to a nytran membrane by blotting in 10 x SSPE solution and Probe the blot
with a-[32P]-labeled fragment of E. coli hph gene or with the P.
anserina URA5 gene. The labeling can be accomplished usint the Primer-A
Gene System (Promaga).
|
|
(Back to
the top) |
|
Results |
|
Transformation frequencies for pAN7-1 and
pWU44 have ranged between 10-200 HmB_resistant colonies and 10-50 protorophs per µg of
plasmid DNA respectively. No significant differences were apparent between electroporation
and PEG-mediated methods. Southern analysis of DNA from putative transformants strongly
suggest integrative transformation is accomplished with both plasmids. |
|
(Back to
the top) |
|
Tips |
|
After preparation by incubation with
Zymolyase, spheroplasts may clump, which affects transformation efficiency. It is
necessary to break the "clumps" of spheroplasts into smaller units and disperse
spheroplasts with appropriate shaking. |
|
(Back to
the top) |
 |
This page updated on:
Monday, March 03, 2003 11:10:07 PM |
|
|
|
|